vs
Side-by-side financial comparison of Natera, Inc. (NTRA) and Primerica, Inc. (PRI). Click either name above to swap in a different company.
Primerica, Inc. is the larger business by last-quarter revenue ($853.7M vs $665.5M, roughly 1.3× Natera, Inc.). Primerica, Inc. runs the higher net margin — 23.1% vs 7.1%, a 16.0% gap on every dollar of revenue. On growth, Natera, Inc. posted the faster year-over-year revenue change (39.8% vs 11.0%). Over the past eight quarters, Natera, Inc.'s revenue compounded faster (34.5% CAGR vs 7.2%).
Natera, Inc. is a clinical genetic testing company based in Austin, Texas that specializes in non-invasive, cell-free DNA (cfDNA) testing technology, with a focus on women’s health, cancer, and organ health. Natera’s proprietary technology combines novel molecular biology techniques with a suite of bioinformatics software that allows detection down to a single molecule in a tube of blood. Natera operates CAP-accredited laboratories certified under the Clinical Laboratory Improvement Amendment...
Primerica, Inc. is a multi-level marketing company that provides insurance, investment and financial services to middle-income families in the United States and Canada.
NTRA vs PRI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $665.5M | $853.7M |
| Net Profit | $47.3M | $197.0M |
| Gross Margin | — | — |
| Operating Margin | -3.4% | 28.9% |
| Net Margin | 7.1% | 23.1% |
| Revenue YoY | 39.8% | 11.0% |
| Net Profit YoY | 187.9% | 17.9% |
| EPS (diluted) | $0.36 | $6.11 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $665.5M | $853.7M | ||
| Q3 25 | $592.2M | $839.9M | ||
| Q2 25 | $546.6M | $793.3M | ||
| Q1 25 | $501.8M | $804.8M | ||
| Q4 24 | $476.1M | $768.8M | ||
| Q3 24 | $439.8M | $774.1M | ||
| Q2 24 | $413.4M | $803.4M | ||
| Q1 24 | $367.7M | $742.8M |
| Q4 25 | $47.3M | $197.0M | ||
| Q3 25 | $-87.5M | $206.8M | ||
| Q2 25 | $-100.9M | $178.3M | ||
| Q1 25 | $-66.9M | $169.1M | ||
| Q4 24 | $-53.8M | $167.1M | ||
| Q3 24 | $-31.6M | $164.4M | ||
| Q2 24 | $-37.5M | $1.2M | ||
| Q1 24 | $-67.6M | $137.9M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 98.0% | ||
| Q1 24 | — | 98.2% |
| Q4 25 | -3.4% | 28.9% | ||
| Q3 25 | -16.5% | 32.3% | ||
| Q2 25 | -20.2% | 29.6% | ||
| Q1 25 | -15.8% | 27.5% | ||
| Q4 24 | -13.6% | 64.7% | ||
| Q3 24 | -8.9% | 32.9% | ||
| Q2 24 | -10.6% | 1.0% | ||
| Q1 24 | -20.2% | 24.1% |
| Q4 25 | 7.1% | 23.1% | ||
| Q3 25 | -14.8% | 24.6% | ||
| Q2 25 | -18.5% | 22.5% | ||
| Q1 25 | -13.3% | 21.0% | ||
| Q4 24 | -11.3% | 21.7% | ||
| Q3 24 | -7.2% | 21.2% | ||
| Q2 24 | -9.1% | 0.1% | ||
| Q1 24 | -18.4% | 18.6% |
| Q4 25 | $0.36 | $6.11 | ||
| Q3 25 | $-0.64 | $6.35 | ||
| Q2 25 | $-0.74 | $5.40 | ||
| Q1 25 | $-0.50 | $5.05 | ||
| Q4 24 | $-0.41 | $4.92 | ||
| Q3 24 | $-0.26 | $4.83 | ||
| Q2 24 | $-0.30 | $0.03 | ||
| Q1 24 | $-0.56 | $3.93 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $756.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $1.7B | $2.4B |
| Total Assets | $2.4B | $15.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $756.2M | ||
| Q3 25 | $1.0M | $644.9M | ||
| Q2 25 | $16.0M | $621.2M | ||
| Q1 25 | $17.8M | $625.1M | ||
| Q4 24 | $22.7M | $687.8M | ||
| Q3 24 | $29.5M | $550.1M | ||
| Q2 24 | $90.3M | $627.3M | ||
| Q1 24 | $69.1M | $593.4M |
| Q4 25 | $1.7B | $2.4B | ||
| Q3 25 | $1.3B | $2.3B | ||
| Q2 25 | $1.2B | $2.3B | ||
| Q1 25 | $1.2B | $2.3B | ||
| Q4 24 | $1.2B | $2.3B | ||
| Q3 24 | $878.5M | $1.9B | ||
| Q2 24 | $836.5M | $2.1B | ||
| Q1 24 | $794.1M | $2.2B |
| Q4 25 | $2.4B | $15.0B | ||
| Q3 25 | $1.8B | $14.8B | ||
| Q2 25 | $1.8B | $14.8B | ||
| Q1 25 | $1.7B | $14.6B | ||
| Q4 24 | $1.7B | $14.6B | ||
| Q3 24 | $1.6B | $14.8B | ||
| Q2 24 | $1.5B | $14.6B | ||
| Q1 24 | $1.5B | $14.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $73.9M | $338.2M |
| Free Cash FlowOCF − Capex | $37.8M | — |
| FCF MarginFCF / Revenue | 5.7% | — |
| Capex IntensityCapex / Revenue | 5.4% | — |
| Cash ConversionOCF / Net Profit | 1.56× | 1.72× |
| TTM Free Cash FlowTrailing 4 quarters | $109.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $73.9M | $338.2M | ||
| Q3 25 | $59.4M | $202.9M | ||
| Q2 25 | $37.6M | $162.6M | ||
| Q1 25 | $44.5M | $197.5M | ||
| Q4 24 | $52.9M | $270.6M | ||
| Q3 24 | $51.8M | $207.3M | ||
| Q2 24 | $4.0M | $173.3M | ||
| Q1 24 | $27.0M | $210.9M |
| Q4 25 | $37.8M | — | ||
| Q3 25 | $37.0M | — | ||
| Q2 25 | $11.7M | — | ||
| Q1 25 | $22.6M | — | ||
| Q4 24 | $34.8M | — | ||
| Q3 24 | $35.5M | — | ||
| Q2 24 | $-7.7M | — | ||
| Q1 24 | $6.7M | — |
| Q4 25 | 5.7% | — | ||
| Q3 25 | 6.2% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 4.5% | — | ||
| Q4 24 | 7.3% | — | ||
| Q3 24 | 8.1% | — | ||
| Q2 24 | -1.9% | — | ||
| Q1 24 | 1.8% | — |
| Q4 25 | 5.4% | — | ||
| Q3 25 | 3.8% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 4.3% | — | ||
| Q4 24 | 3.8% | — | ||
| Q3 24 | 3.7% | — | ||
| Q2 24 | 2.8% | — | ||
| Q1 24 | 5.5% | — |
| Q4 25 | 1.56× | 1.72× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 0.91× | ||
| Q1 25 | — | 1.17× | ||
| Q4 24 | — | 1.62× | ||
| Q3 24 | — | 1.26× | ||
| Q2 24 | — | 147.98× | ||
| Q1 24 | — | 1.53× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NTRA
Segment breakdown not available.
PRI
| Revenues From Sources Other Than Contracts With Customers | $445.9M | 52% |
| Investment And Savings Products Segment Revenues | $340.3M | 40% |
| Other | $56.5M | 7% |
| Segment Revenues From Contracts With Customers | $11.0M | 1% |
